Xifaxan

Why Shares of Bausch Health Soared Wednesday
Motley Fool
Wed, 05/17/23 - 10:42 pm
Bausch Health
IBS
Xifaxan
patents
legal
On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega
Fierce Pharma
Wed, 12/7/22 - 10:10 am
ICER
drug pricing
Bausch Health
Xifaxan
JNJ
Invega
Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic
Fierce Pharma
Mon, 08/1/22 - 10:33 am
Bausch Health
IBS-d
Xifaxan
legal
Norwich Pharmaceuticals
generics
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Fierce Pharma
Mon, 01/29/18 - 11:57 pm
Valeant Pharmaceuticals
Cosmo Pharma
rifamycin SV
IBS-d
Xifaxan
Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Fierce Pharma
Tue, 03/21/17 - 06:58 pm
Valeant Pharmaceuticals
Xifaxan
generics
FDA
IBS-d
Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor
Yahoo
Wed, 11/30/16 - 09:38 am
Valeant Pharmaceuticals
drug reps
primary care
Relistor
Xifaxan
Valeant salesforce stabilizes as Xifaxan rebounds
Medical Marketing and Media
Wed, 08/10/16 - 11:42 am
Valeant Pharmaceuticals
drug reps
Xifaxan
Valeant CEO blames salesforce turnover for disappointing Xifaxan sales
Medical Marketing and Media
Wed, 06/8/16 - 03:09 pm
Valeant Pharmaceuticals
Joseph Papa
Xifaxan
sales force
drug reps
Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Fierce Pharma Marketing
Mon, 06/1/15 - 12:18 pm
Valeant Pharmaceuticals
DTC
Xifaxan
Actavis
IBS
Viberzi
FDA approves Actavis, Valeant drugs for irritable bowel syndrome
Yahoo/Reuters
Wed, 05/27/15 - 08:27 pm
FDA
Actavis
Valeant Pharmaceuticals
IBS
irritable bowel syndrome
Xifaxan
Viberzi
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Valeant Pharmaceuticals
Actavis
Xifaxan
Orkambi
Vertex Pharmaceuticals
Regeneron
Sanofi
Amgen
Repatha
eluxadoline
Praluent
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Earnings Preview: Declining Sales Of Xifaxan As Valeant Deal Looms
Bidness Etc.
Mon, 03/2/15 - 04:38 pm
Salix
earnings
Xifaxan
Valeant Pharmaceuticals
M&A
Salix’s Xifaxan Sales Expected To Go Downhill
Bidness Etc.
Wed, 10/8/14 - 11:04 am
Salix
Xifaxan
hepatitis C
Why Salix Pharmaceuticals' Good Data Wasn't Great
Motley Fool
Wed, 07/2/14 - 09:57 am
Salix
Xifaxan
Salix Pharma Hits A New High On Bullish Clinical-Trial Data
Yahoo/Investors Business Daily
Wed, 07/2/14 - 12:00 am
Salix
clinical trials
Xifaxan
IBS-d
The FDA's Drug Approval Agenda for Next Week
Seeking Alpha
Thu, 06/16/11 - 11:42 am
FDA
Xifaxan
Salix
IBS
Remoxy
Durect Corporation
Pain Therapeutics
Pfizer
painkillers
Salix's IBS drug fails to get FDA nod
Reuters
Tue, 03/8/11 - 11:48 am
FDA
Salix
IBS
irritable bowel syndrome
Xifaxan
Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual Meeting of the American Association for the Study of Liver Diseases
MarketWatch
Sat, 10/30/10 - 01:17 pm
Salix
Xifaxan
hepatic encephalopathy